3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Plasma cell
2
Conditions
Breast Neoplasms
37
Melanoma
17
Prostatic Neoplasms
16
Lung Neoplasms
14
Neoplasms
13
Squamous Cell Carcinoma of Head and Neck
10
Neoplasm Metastasis
9
Carcinoma, Non-Small-Cell Lung
9
Precancerous Conditions
8
Lymphoma
8
Uterine Cervical Neoplasms
6
Pancreatic Neoplasms
6
Leukemia
6
Esophageal Neoplasms
6
Colorectal Neoplasms
6
Colonic Neoplasms
6
Breast Neoplasms, Male
6
Urinary Bladder Neoplasms
5
Rectal Neoplasms
5
Myelodysplastic Syndromes
5
Lymphoma, Follicular
5
Leukemia, Myeloid, Acute
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Head and Neck Neoplasms
5
Barrett Esophagus
5
Adenocarcinoma Of Esophagus
5
Salivary Gland Neoplasms
4
Recurrence
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Interventions
Dexamethasone
12
Melphalan
7
Calcium Dobesilate
6
Lenalidomide
5
Bortezomib
5
Cyclophosphamide
4
miridesap
3
ixazomib
2
Doxycycline
2
Biopsy
2
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
2
pomalidomide
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
carfilzomib
1
birtamimab
1
auricularum
1
Vinorelbine
1
Thalidomide
1
Tacrolimus
1
Pharmaceutical Preparations
1
Interleukin-2
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Gemcitabine
1
Filgrastim
1
Etanercept
1
Drug Evaluation
1
Blood Specimen Collection
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Amyloidosis
×
Biopsy
×
Clear all
NCT03886155
2021-12-22
CAST
The Cleveland Clinic
Completed
107 enrolled
NCT03923920
2021-12-22
ALF
The Cleveland Clinic
Completed
200 enrolled